Monday, April 19, 2021
HomeEndometriosisEndometriosis ResearchEvaluating hematological parameters in women with endometriosis

Evaluating hematological parameters in women with endometriosis

Endometriosis is still a poorly understood disease. At G.O. Institute we are constantly looking for the most updated information regarding endometriosis treatment. This is an interesting article which we hope will help you understand at least this part of endometriosis treatment.  We know that inflammation is a factor for a lot of chronic diseases and endometriosis appears to be one of them.  This study calls out the need to check inflammatory markers to see how treatment is progressing.  Overall though, more research is required to see what needs to be measured exactly and when.

If this article seems to be relevant to your situation, please contact us and Dr. Steven Vasilev, our director. Since we are monitoring this research as it gets published, we can use it to help you beat endometriosis and get your life back. Dr. Steven Vasilev is a renowned minimally invasive endometriosis excision expert, focusing on recurrent and advanced endometriosis excision.

J Obstet Gynaecol. 2021 Jan 18:1-6. doi: 10.1080/01443615.2020.1845634. Online ahead of print.


In the present study, we aimed to evaluate the relationship between the level of hematological parameters and the presence and stage of endometriosis. We included medical records of patients diagnosed with endometriosis (endometriosis group) and patients diagnosed with benign non-endometriotic ovarian masses (control group), who were eligible based on inclusion and exclusion criteria and compared the preoperative level of hematological parameters between the two groups. According to our findings, neutrophil and WBC counts, mean platelet volume, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) were significantly higher, and the haemoglobin concentration, platelet count, and absolute lymphocyte count were lower in women diagnosed with endometriosis compared to the control group. There was no significant difference in hematological parameters of patients with endometriosis stages III and IV. Finally, we found that the preoperative level of hematological parameters lacked sufficient power for the diagnosis of endometriosis. Also, our results indicate that endometriosis is associated with an inflammatory processes. IMPACT STATEMENT What is already known on this subject? Inflammatory factors are believed to be involved in the pathogenesis of endometriosis; however, there are inconsistent reports on the association between blood inflammatory markers and endometriosis. What do the results of this study add? The results of this study indicate that endometriosis is associated with inflammatory processes that lead to changes in hematological parameters; however, preoperative measurement of these parameters has not sufficient power for the diagnosis of endometriosis. What are the implications of these findings for clinical practice and/or further research? The preoperative level of hematological parameters lacks sufficient power for the diagnosis of endometriosis, but they may help doctors make a diagnosis in the clinical setting as auxiliary findings.

PMID:33459084 | DOI:10.1080/01443615.2020.1845634

Ashraf Moini

This book by Dr. Steven Vasilev MD can help women with ovarian cysts, masses and tumors of all types, including endometriosis and endometriomas.  He is a world-renowned expert on this topic.

To discover more about endometriosis and our unique treatment approach, please READ THIS

Dr Steve Vasilev MD
“I help and guide women to defeat gynecologic cancers and advanced pelvic conditions such as endometriosis, using a unique combination of minimally invasive robotic surgery, precision medicine therapies and complementary holistic natural support towards thriving in survivorship." Dr. Vasilev is the only physician quadruple board certified in Ob-Gyn, Gynecologic Oncology and Integrative & Holistic Medicine in the United States. He is an accomplished advanced robotic surgeon and serves as Medical Director of Integrative Medicine and Integrative Gynecologic Oncology at Providence Saint John's Health Center, Professor at John Wayne Cancer Institute in Santa Monica, California and is Clinical Professor at Loma Linda University School of Medicine. He is former faculty and professor at UC Irvine, UCLA, USC and City of Hope. He is an active member of multiple medical societies and has been nationally listed in "Best Doctors" for 18 years.

Most Popular